(Total Views: 614)
Posted On: 08/12/2022 12:13:21 AM
Post# of 145888
“A Phase Ib/II Study of Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ Metastatic Triple Negative Breast Cancer (mTNBC)”
(0)
(0)